Donald Trump underestimates the difficulty of producing in America—and how his own policies will make it harder ...

(Reuters) -U.S. corporations have been ramping up their security spending, but following the murder of UnitedHealth (NYSE: ...

The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...

The EURO STOXX 50 Index is up 16.37 points or 0.32% today to 5170.49 --Largest five day point and percentage gain since Wednesday, April 16, 2025 --Longest winning streak since Friday, Jan. 24, 2025, ...

Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

IBM is making a major bet on America's tech future. The company announced plans on Monday to invest $150 billion across the ...

Six years into espnW Summit NYC, brands increasingly want in on the gathering of institutional women's sports knowledge. In ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE ...

PHARMACEUTICAL companies have invested more than US$150bn in US manufacturing and R&D since the election of Donald Trump, ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...